Дапаглифлозин/Метформин Полфарма

Дапаглифлозин/Метформин Полфарма combines two active ingredients to support blood sugar management in adults with type 2 diabetes. This oral medication is prescribed alongside diet and exercise for better glycemic control. It belongs to the SGLT2 inhibitor and biguanide classes. Always follow your healthcare provider’s guidance when using this combination therapy.

This combination medication is primarily used to improve blood sugar levels in adults with type 2 diabetes. It may be prescribed when diet and exercise alone are not enough to maintain healthy glucose levels. The two active ingredients work together to reduce sugar absorption and increase its excretion. It is often used alongside other diabetes treatments as directed by a doctor.

Users may experience improved blood sugar control as the medication helps the body manage glucose more effectively. Some people notice changes in urination frequency due to how the medication works in the kidneys. It does not cause immediate blood sugar spikes or crashes when taken as prescribed. Individual responses may vary based on diet, activity, and overall health.

Store this medication at room temperature away from moisture and heat. Keep it out of reach of children and pets. Do not use if the packaging is damaged or the tablets show signs of tampering. Inform your healthcare provider about all medications and supplements you are taking before starting this treatment.

This medication may interact with diuretics, insulin, or other diabetes drugs, potentially affecting blood sugar levels. Alcohol use may increase the risk of lactic acidosis or low blood sugar when combined with metformin. Certain medications, such as CYP3A4 inhibitors or inducers, may alter how dapagliflozin works in the body. Always review your full medication list with a healthcare professional.